2016
DOI: 10.14814/phy2.12709
|View full text |Cite
|
Sign up to set email alerts
|

Growth hormone (GH)-transgenic insulin-like growth factor 1 (IGF1)-deficient mice allow dissociation of excess GH and IGF1 effects on glomerular and tubular growth

Abstract: Growth hormone (GH)‐transgenic mice with permanently elevated systemic levels of GH and insulin‐like growth factor 1 (IGF1) reproducibly develop renal and glomerular hypertrophy and subsequent progressive glomerulosclerosis, finally leading to terminal renal failure. To dissociate IGF1‐dependent and ‐independent effects of GH excess on renal growth and lesion development in vivo, the kidneys of 75 days old IGF1‐deficient (I −/−) and of IGF1‐deficient GH‐transgenic mice (I −/− /G), as well as of GH‐transgenic (… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
37
0

Year Published

2019
2019
2025
2025

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 29 publications
(38 citation statements)
references
References 56 publications
1
37
0
Order By: Relevance
“…GH transgenic mice displayed significant effacement in podocyte foot processes that resulted in impaired glomerular function [6]. In this study, we observed altered podocyte permeability to BSA as evidenced by paracellular influx assay performed with podocyte monolayers treated either with GH CM or TGF-β conditions.…”
Section: Former One Suggests Autocrine and Later Suggest Paracrine Acmentioning
confidence: 52%
See 2 more Smart Citations
“…GH transgenic mice displayed significant effacement in podocyte foot processes that resulted in impaired glomerular function [6]. In this study, we observed altered podocyte permeability to BSA as evidenced by paracellular influx assay performed with podocyte monolayers treated either with GH CM or TGF-β conditions.…”
Section: Former One Suggests Autocrine and Later Suggest Paracrine Acmentioning
confidence: 52%
“…Podocyte loss leaves GBM denuded and provokes neighboring podocytes to undergo compensatory hypertrophy.However, the molecular signals that initiate the podocyte or glomerular hypertrophy remains unclear.Elevated growth hormone (GH) levels in poorly controlled type 1 diabetes mellitus (DM) is implicated as a causative factor in the development of renal aberrations and proteinuria [2][3][4].GH transgenic animals developed significant renal hypertrophy and glomerulosclerosis [5].Albeit, part of the biological effects of GH are mediated by insulin-like growth factor 1 (IGF-1), the glomerular hypertrophy and significant renal manifestations are evidenced in GH transgenics with IGF-1 null background suggesting that GH, but not IGF-1 responsible for glomerular hypertrophy [6]. In GH transgenic animals, podocytes undergo hypertrophy while mesangial and endothelial cells undergo proliferation [6]. GH administration pronounced the usual renal hypertrophy and it was aggravated in streptozotocin (STZ)-induced diabetic rats [5].Mice with mutant GHR were protected from STZ-induced diabetic renal complications [7].…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Even though the data we present are associative, it does not fully prove causality. However, we think that this study provides another evidence for the repeated clinical observations on the relative safety of chronic GH supplementation for children with CKD [3, 25], in spite of the theoretical concerns arising from the GH-transgenic mouse model [14, 15].…”
Section: Discussionmentioning
confidence: 99%
“…Medrano and Casellas [12] have described also a decreased life span for hg/hg mice, in 2 genetic backgrounds, in association with increased subcutaneous fibrosis and collagen deposition [13]. Since GH overexpression (in GH transgenic mice) causes glomerulosclerosis [14, 15], the goal of this study was to test the effects of SOCS2 silencing on kidney damage and body growth in a mouse model of CKD.…”
Section: Introductionmentioning
confidence: 99%